OptimizeRx Stock

OptimizeRx EBIT per Share

The EBIT per Share of OptimizeRx (OPRX) as of Jul 24, 2026 is -0.34 USD. In the previous year, EBIT per Share was -1.02 USD — a change of -66.78% (higher).

EBIT per Share

-0.34USD

YoY

-66.78%

Last updated:

EBIT per Share of OptimizeRx is 2026 -0.34 USD. EBIT per Share of OptimizeRx was 2025 -1.02 USD. It decreases by -66.78% higher compared to the previous year.
Access this data via the Eulerpool API

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

EBIT per Share of OptimizeRx is -0.34 USD in 2026.

Access this data via the Eulerpool API

Income Statement — OptimizeRx

All Key Metrics — OptimizeRx